Nanobiotix

Research Nanobiotix (NBTX) on Bullrun: market cap USD 1.82B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNBTX
• ExchangeNASDAQ
• CountryFrance
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.82B
• Financial periodQ4 2025
• RevenueUSD 29.64M
• Net income-USD 23.96M
• Free cash flow-USD 33.97M

Valuation Snapshot

latest market cap is USD 1.82B.

About Nanobiotix

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer.

Frequently asked questions

What is Nanobiotix's market cap?

Nanobiotix's market capitalization is USD 1.82B.

What does Nanobiotix do?

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.